Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity
Erin D. Lucas, Johnathon Schafer, Jennifer L. Matsuda, et al.
Cell Reports (2020) Vol. 33, Iss. 2, pp. 108258-108258
Open Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
Saraí G De León-Rodríguez, Paul Hernández‐Herrera, Cristina Aguilar-Flores, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 9
CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization
Ana Isabel Sebastião, Daniela Mateus, Mylène A. Carrascal, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 825-825
Open Access | Times Cited: 5
Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design
Yichao Lu, Jian You
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114457-114457
Open Access | Times Cited: 5
Absence of PD-L1 signaling hinders macrophage defense against Mycobacterium tuberculosis via upregulating STAT3/IL-6 pathway
Peijie Qu, Xinyu Li, Weihuang Liu, et al.
Microbes and Infection (2024) Vol. 26, Iss. 5-6, pp. 105352-105352
Closed Access | Times Cited: 1
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by18F-BMS-986192 PET: pooled analysis of data from four solid tumor types
Iris H.C. Miedema, Johanna E. E. Pouw, Anne Kwakman, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008899-e008899
Open Access | Times Cited: 1
Leukocyte Trafficking in Lymphatic Vessels
Aline Bauer, Hazal Tatliadim, Cornelia Halin
Cold Spring Harbor Perspectives in Medicine (2022) Vol. 12, Iss. 10, pp. a041186-a041186
Closed Access | Times Cited: 6
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Yiru Long, Xiaolu Yu, Runqiu Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
Marjan Azin, Kenneth Ngo, Jennet Hojanazarova, et al.
JID Innovations (2023) Vol. 3, Iss. 6, pp. 100221-100221
Open Access | Times Cited: 3
Contributions of PD‐L1 reverse signaling to dendritic cell trafficking
Beth A. Jirón Tamburini
FEBS Journal (2021) Vol. 289, Iss. 20, pp. 6256-6266
Open Access | Times Cited: 7
Programmed death ligand 1 intracellular interactions with STAT3 and focal adhesion protein Paxillin facilitate lymphatic endothelial cell remodeling
Johnathon Schafer, Erin D. Lucas, Monika Dzieciątkowska, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102694-102694
Open Access | Times Cited: 4
Platelet PD-L1 inhibits storage-induced apoptosis by sustaining activation of the AKT signalling pathway
Shaoheng Chen, Jia Han, Huimin Deng, et al.
Thrombosis Research (2024) Vol. 240, pp. 109056-109056
Closed Access
Targeted Delivery of STING Agonist via Albumin Nanoreactor Boosts Immunotherapeutic Efficacy against Aggressive Cancers
Zhijun Miao, Song Xue, Anan Xu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1216-1216
Open Access
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Athina Boumpas, Antonis Papaioannou, Pavlos Bousounis, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
More than a ligand: PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I interferon pathway
Jonathan J. Hodgins, John Abou-Hamad, Ash Hagerman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis
Athina Boumpas, Antonis Papaioannou, Pavlos Bousounis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells
Anudari Letian, Eyoel Yemanaberhan Lemma, Paola Cavaliere, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Previous Page - Page 2

Scroll to top